You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
© 2025. This work is published under http://creativecommons.org/licenses/by/4.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Abstract
Background
Episodic memory function in aging varies considerably both across individuals and within individuals over time. Identifying factors that explain variance in memory is important for improving prediction of risk for cognitive decline in older adults. Here we examine associations of structural, functional, and molecular factors with cross‐sectional and longitudinal memory function in a normal aging cohort.
Method
Participants were enrolled in the Stanford Aging and Memory Study (SAMS; N = 212; mean age: 69.5 ± 5.8 years, 57% female) and cognitively unimpaired at baseline. As part of an ongoing longitudinal extension of SAMS, a subset of participants (N = 79) have returned for longitudinal cognitive assessment (mean follow‐up: 7.08 ± 1.14 years). Memory was assessed using a composite score comprised of delayed recall subtests from Logical Memory, Hopkins Verbal Learning Test and the Brief Visual Memory Test. Baseline predictors of interest included Lumipulse CSF pTau181, hippocampus volume from manually segmented T2‐structural MRI, and fMRI measures of neural selectivity and cortical reinstatement measured during associative memory encoding and retrieval, respectively. Linear models and linear mixed effects models examined cross‐sectional and longitudinal associations, respectively, between predictors of interest and memory performance. All models included age, sex, and education as covariates.
Result
All baseline predictors exhibited significant associations with age (p < .005). Among baseline predictors, associations were observed between reinstatement and neural selectivity (β = 0.37, p < .001) and between reinstatement and CSF pTau181 (β = ‐0.20, p < .05). Cross‐sectional effects with the memory composite were observed across both functional measures (neural selectivity: β = 0.20, p < .01; reinstatement: β = 0.20, p < .001). Associations with CSF pTau (p < .001) and hippocampus volume (p < .01) were observed when examining longitudinal change in memory over time. A trend level association between neural selectivity and longitudinal memory performance was also present (p = .07).
Conclusion
Functional, structural, and molecular markers relevant for aging and Alzheimer's disease independently impact memory performance in human aging. Combining these measures may improve the prediction of clinically meaningful decline and elucidate factors that promote cognitive maintenance in older age.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Stanford University School of Medicine, Stanford, CA, USA
2 Stanford University, Stanford, CA, USA, Wu Tsai Neuroscience Institute, Stanford, CA, USA
3 Stanford University, Stanford, CA, USA
4 Stanford University School of Medicine, Stanford, CA, USA, Wu Tsai Neuroscience Institute, Stanford, CA, USA
5 University of Oregon, Eugene, OR, USA





